Contract development and manufacturing organization (CDMO) Akums Drugs and Pharmaceutical Limited has announced the launch of a Combikit approved by the drug regulator for the healing of duodenal ulcers associated with helicobacter pylori (H. pylori) and eradication of H. pylori in patients with active or healed peptic ulcer.
The Combikit
